CI vs DGX
Cigna (CI) and Quest Diagnostics (DGX) compared side by side. Cigna (CI) is larger, with a market cap of $81.1B versus $26.7B for Quest Diagnostics, about 3.0 times the size. On trailing earnings, CI is cheaper at 12.7x versus 24.1x for DGX.
Head to head
| Metric | CI | DGX |
|---|---|---|
| Market cap | $81.1B | $26.7B |
| P/E (TTM) | 12.7x | 24.1x |
| Forward P/E | 9.2x | 20.2x |
| Revenue (TTM) | — | $11.8B |
| Revenue growth | — | 10.0% |
| Gross margin | — | 33.2% |
| Operating margin | — | 15.6% |
| Free cash flow | $9.1B | $1.3B |
| Dividend yield | 2.03% | 1.42% |
| 1-year return | +2.9% | +34.2% |
| 5-year return (annual) | +9.3% | +12.7% |
| Max drawdown | -84% | -49% |
| FI Handbook grade | A | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
CI vs DGX FAQ
Which is bigger, CI or DGX?
Cigna (CI) is larger, with a market cap of $81.1B versus $26.7B for Quest Diagnostics, about 3.0 times the size.
Is CI or DGX cheaper?
On trailing earnings, CI is cheaper at 12.7x versus 24.1x for DGX. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, CI or DGX?
DGX returned +34.2% over the past year including dividends, versus +2.9% for CI, through October 23, 2026.
Which pays a higher dividend, CI or DGX?
CI yields 2.03% versus 1.42% for DGX.
Full pages: Cigna · Quest Diagnostics